Skip to main content

Day: March 17, 2026

Compagnie de l’Odet : Results for fiscal year 2025

                                                                         COMPAGNIE DE L’ODETResults for fiscal year 2025 March 17, 2026  Net profit, Group share: €218 million Proposal to pay a dividend of €4.80 per share, an increase of 9% Revenue: €2,924 million, -9% at constant scope and exchange rates. Adjusted operating income (EBITA (1) (2)): €282 million including the results of the equity-accounted associates UMG, Canal+, Louis Hachette Group, Havas and Vivendi for the full year 2025. Net income: €354 million, compared with €1,750 million in 2024, which included the net capital gain on the disposal of Bolloré Logistics (+€3.7 billion) and the capital loss on the deconsolidation of companies resulting from the spin-off of Vivendi (-€1.9 billion). Net income, Group share: €218 million. Net cash position: €5,126 million...

Continue reading

Virbac: 2025 annual results

A robust adjusted EBIT margin² of 16.3% at CERS, driven by solid organic revenue growth of 7.9%Solid 2025 dynamic with annual revenue up +7.9% at CERS; with strong momentum in key categories and countries. Volume/mix effect of ~+5%, completed by price increase of ~+3% Adjusted EBIT (before amortization of assets arising from acquisitions) margin of 16.3% at CERS despite:temporary shutdown of an antigen’s production site and higher inventory write-offs in FY25 partially offset by a solid underlying performance on sales prices and product mix and; improving operating expense to revenue ratio. Consolidated net income increased by +3.2% and amounts to €150.5m Strong cash generation of €93 million funded the Thyronorm acquisition while maintaining a relatively stable net debt at €172.8 million compared to €168.5 million at the end of...

Continue reading

Bolloré : Results for fiscal year 2025

              Results for fiscal year 2025 March 17, 2026Net income, Group share: €348 million Proposed ordinary dividend of €0.08 and exceptional dividend of €1.5 per share Revenue: €2,926 million, -9% at constant scope and exchange rates. Adjusted operating income (EBITA(1) (2)): €286 million including the results of the equity-accounted associates UMG, Canal+, Louis Hachette Group, Havas and Vivendi for the full year 2025. Net income: €351 million, compared with €1,840 million in 2024, which included the net capital gain on the disposal of Bolloré Logistics (+€3.6 billion) and the capital loss on the deconsolidation of companies resulting from the spin-off of Vivendi (-€1.9 billion). Net income, Group share: €348 million. Net cash position: €5,619 million at December 31, 2025 (compared with €5,306 million...

Continue reading

SANOMA CORPORATION: ACQUISITION OF OWN SHARES 17 March 2026

Sanoma Corporation, Stock exchange release, 17 March 2026 at 18:30 EET SANOMA CORPORATION: ACQUISITION OF OWN SHARES 17 March 2026 Nasdaq Helsinki Ltd:Date 17 March 2026  Exchange transaction Buy  Share class SANOMA  Amount 26,384  Average price/share, EUR 9.2567  Highest price/share, EUR 9.3500  Lowest price/share, EUR 9.2200  Total cost, EUR 244,228.77       The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 and the Commission Delegated Regulation (EU) 2016/1052. The company holds a total of 897,901 of its own shares (SANOMA) including the shares acquired on 17 March 2026. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Sanoma Corporation Skandinaviska Enskilda Banken AB...

Continue reading

Lassila & Tikanoja Plc: Share Repurchase 17.3.2026

Lassila & Tikanoja Plc, STOCK EXCHANGE RELEASE, 17 March 2026 at 6.30 PM (EET)              Lassila & Tikanoja Plc: Share Repurchase 17.3.2026         In the Helsinki Stock Exchange             Trade date           17.3.2026    Bourse trade         Buy    Share                  LASTIK    Amount             10 000 Shares  Average price/ share    7,8100 EUR  Total cost            78 100,00 EUR                Lassila & Tikanoja Plc now holds a total of 105 712 shares  including the shares repurchased on 17.3.2026           The share buybacks are executed in compliance with Regulation   No. 596/2014 of the European Parliament and Council (MAR) Article 5and the Commission Delegated Regulation (EU) 2016/1052.                On behalf of Lassila & Tikanoja...

Continue reading

Announcement of net asset value of INVL Baltic Real Estate on 31 December 2025

The net asset value of INVL Baltic Real Estate, as provided in the Articles of Association section XI ‘Valuation of assets of the company and calculation of the net asset value’, amounted to EUR 28,134,307 or EUR 3.5465 per share on 31 December 2025. The person authorized to provide additional information:Real Estate Fund Manager of Management CompanyVytautas BakšinskasE-mail vytautas.baksinskas@invl.com

Continue reading

Audited results of INVL Baltic Real Estate group of 2025

The audited consolidated net profit of INVL Baltic Real Estate group amounted to EUR 3.67 million, the revenue was EUR 4.1 million for the period of 2025 (for 2024 – consolidated net profit was EUR 2.74 million, revenue was EUR 4 million). The audited net profit of INVL Baltic Real Estate itself amounted to EUR 3.67 million in 2025 and EUR 2.74 million in 2024. The annual information is published in the European Single Electronic Format (ESEF) in compliance with the requirements of Commission Delegated Regulation (EU) 2019/815 of 17 December 2018 (zip file attached). This is the official format for the annual information that will be approved by the Ordinary General Shareholders‘ Meeting. The annual information is additionally provided in pdf format as a copy of the published ESEF information. Additional information: The real estate investment...

Continue reading

UPDATED — ZenaTech Develops Low-Cost, Single-Use Autonomous Interceptor Drone for ZenaDrone’s Counter-UAS System for US Defense, Middle East, and Ukraine Use

Designed to defeat enemy drones at a fraction of the cost of conventional air defense systems VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces that its ZenaDrone subsidiary has initiated development of a prototype for a small, one-way interceptor drone designed to stop hostile drones by physically intercepting them in flight. The prototype, called Interceptor P-1, is an autonomous and expendable vertical takeoff and landing (VTOL)-design drone that can be added to the company’s counter-UAS (Unmanned Aircraft System) defense system offering dramatically lower costs than traditional...

Continue reading

National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder

Jails outpace prisons in offering MOUD, but regional disparities and limited treatment access persist across the U.S. Qualitative feedback points to need for greater reentry support, housing, care coordination, and provider trainingRICHMOND, Va., March 17, 2026 (GLOBE NEWSWIRE) — Indivior Pharmaceuticals Inc. (Nasdaq: INDV) announced results from a cross-sectional survey published in the Journal of Correctional Health Care that reveal critical gaps in the availability of medications for opioid use disorder (MOUD) across U.S. correctional facilities. Funded by Indivior and conducted in partnership with the National Commission on Correctional Health Care (NCCHC), the study surveyed 212 jails, prisons, and detention centers. Findings indicate that just 58% offer at least one FDA-approved MOUD and stark disparities in treatment access...

Continue reading

UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets Virtual Healthcare Forum

NEWBURYPORT, Mass., March 17, 2026 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that President Mitchell Rock and Chief Financial Officer Ron Lataille will participate in a virtual fireside chat at the upcoming KeyBanc Capital Markets Virtual Healthcare Forum on March 18, 2026, beginning at approximately 10:30 AM ET. About UFP Technologies, Inc.UFP Technologies is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. UFP is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world’s top medical device manufacturers. The Company’s single-use and single-patient devices...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.